selenium

logo.jpg (8393 bytes)
information guide over kanker

 

Selenium


Selenium and cancer

Observational studies indicate that death from cancer, including lung, colorectal, and prostate cancers, is lower among people with higher blood levels or intake of selenium [34-40]. In addition, the incidence of nonmelanoma skin cancer is significantly higher in areas of the United States with low soil selenium content [37]. The effect of selenium supplementation on the recurrence of different types of skin cancers was studied in seven dermatology clinics in the U.S. from 1983 through the early 1990s. Taking a daily supplement containing 200 µg of selenium did not affect recurrence of skin cancer, but significantly reduced the occurrence and death from total cancers. The incidence of prostate cancer, colorectal cancer, and lung cancer was notably lower in the group given selenium supplements [41].

Research suggests that selenium affects cancer risk in two ways. As an anti-oxidant, selenium can help protect the body from damaging effects of free radicals. Selenium may also prevent or slow tumor growth. Certain breakdown products of selenium are believed to prevent tumor growth by enhancing immune cell activity and suppressing development of blood vessels to the tumor [42].

However, not all studies have shown a relationship between selenium status and cancer. In 1982, over 60,000 participants of the Nurse's Health Study with no history of cancer submitted toenail clippings for selenium analysis. Toenails are thought to reflect selenium status over the previous year. After three and a half years of data collection, researchers compared toenail selenium levels of nurses with and without cancer. Those nurses with higher levels of selenium in their toenails did not have a reduced risk of cancer [43].

Two important long-term studies, the SU.VI.MAX study in France and the Selenium and Vitamin E Cancer Prevention Trial (SELECT) study in the U.S., are now underway to further investigate the selenium/cancer prevention link.

The SU.VI.MAX Study is a prevention trial looking at the effects of antioxidant vitamins and minerals on chronic diseases such as cancer and cardiovascular disease. Doses of the nutrients provided in the study are one to three times higher than recommended intakes, including a daily supplement of 100 µg selenium. The SU.VI.MAX study, which began in 1994, has followed more than 12,000 adult men and women. This study was designed to continue for eight years, and the research community is eagerly awaiting the results of this study [44].

The SELECT study, a long-term study sponsored by the NIH, is investigating whether supplemental selenium and/or vitamin E can decrease the risk of prostate cancer in healthy men. Past evidence as well as pre-clinical trials for the SELECT study suggests that these two nutrients may be effective in preventing prostate cancer. A daily supplement containing 200 µg of selenium will be given to individuals in the selenium-only study group, while men in the combined-nutrients group will receive a daily supplement containing 200 µg selenium and 400 mg vitamin E. The study, which will span from 2001 to 2013, will include 32,400 healthy adult men [45].

  1. Thomson CD. Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr 2004;58:391-402.
  2. Goldhaber SB. Trace element risk assessment: essentiality vs. toxicity. Regulatory Toxicology and Pharmacology. 2003;38:232-42.
  3. Combs GF, Jr and Gray WP. Chemopreventive agents: Selenium. Pharmacol Ther 1998; 79:179-92.
  4. McKenzie RC, Rafferty TS, Beckett GJ. Selenium: an essential element for immune function. Immunol Today 1998;19:342-5.
  5. Levander OA. Nutrition and newly emerging viral diseases: An overview. J Nutr 1997;127: 948S-50S. [PubMed abstract]
  6. Arthur JR. The role of selenium in thyroid hormone metabolism. Can J Physiol Pharmacol 1991;69:1648-52. [PubMed abstract]
  7. Corvilain B, Contempre B, Longombe AO, Goyens P, Gervy-Decoster C, Lamy F, Vanderpas JB, Dumont JE. Selenium and the thyroid: How the relationship was established. Am J Clin Nutr 1993;57 (2 Suppl):244S-8S. [PubMed abstract]
  8. Longnecker MP, Taylor PR, Levander OA, Howe M, Veillon C, McAdam PA, Patterson KY, Holden JM, Stampfer MJ, Morris JS, Willett WC. Selenium in diet, blood, and toenails in relation to human health in a seleniferous area. Am J Clin Nutr 1991;53:1288-94. [PubMed abstract]
  9. Pennington JA and Schoen SA. Contributions of food groups to estimated intakes of nutritional elements: Results from the FDA total diet studies, 1982-91. Int J Vitam Nutr Res 1996;66:342-9. [PubMed abstract]
  10. Pennington JA and Young BE. Total diet study nutritional elements. J Am Diet Assoc 1991;91:179-83. [PubMed abstract]
  11. U.S. Department of Agriculture, Agricultural Research Service. 2003. USDA National Nutrient Database for Standard Reference, Release 16. Nutrient Data Laboratory Home Page, http://www.nal.usda.gov/fnic/foodcomp.
  12. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes: Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academy Press, Washington, DC, 2000.
  13. Bialostosky K, Wright JD, Kennedy-Stephenson J, McDowell M, Johnson CL. Dietary intake of macronutrients, micronutrients and other dietary constituents: United States 1988-94. Vital Heath Stat. 11(245) ed: National Center for Health Statistics, 2002.
  14. Zhou BF, Stamler J, Dennis B, Moag-Stahlberg A, Okuda N, Robertson C, Zhao L, Chan Q, Elliott P for the INTERMAP Research Group. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the alte 1990s: The INTERMAP Study. J of Human Hypertension. 2003;17:623-30.
  15. Ellis DR and Salt DE. Plants, selenium and human health. Curr Opin Plant Biol 2003;6:273-9.
  16. Combs GF. Food system-based approaches to improving micronutrient nutrition: the case for selenium. Biofactors 2000;12:39-43.
  17. Zimmerman MB and Kohrle J. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid 2002;12:867-78.
  18. Beck MA, Levander O, Handy J. Selenium deficiency and viral infection. J of Nutr 2003;133:1463S-67S.
  19. Levander OA and Beck MA. Interacting nutritional and infectious etiologies of Keshan disease. Insights from coxsackie virus B-induced myocarditis in mice deficient in selenium or vitamin E. Biol Trace Elem Res 1997;56:5-21. [PubMed abstract]
  20. Levander OA. Scientific rationale for the 1989 recommended dietary allowance for selenium. J Am Diet Assoc 1991;91:1572-6. [PubMed abstract]
  21. Gramm HJ, Kopf A, Bratter P. The necessity of selenium substitution in total parenteral nutrition and artificial alimentation. J Trace Elem Med Biol 1995;9:1-12. [PubMed abstract]
  22. Abrams CK, Siram SM, Galsim C, Johnson-Hamilton H, Munford FL, Mezghebe H. Selenium deficiency in long-term total parenteral nutrition. Nutr Clin Pract 1992;7:175-8. [PubMed abstract]
  23. Rannem T, Ladefoged K, Hylander E, Hegnhoj J, Staun M. Selenium depletion in patients with gastrointestinal diseases: Are there any predictive factors? Scand J Gastroenterol 1998;33:1057-61. [PubMed abstract]
  24. Kuroki F, Matsumoto T, Lida M. Selenium is depleted in Crohn's disease on enteral nutrition. Digestive Diseases 2003;21:266-70.
  25. Rannem T, Ladefoged K, Hylander E, Hegnhoj J, Jarnum S. Selenium status in patients with Crohn's disease. Am J Clin Nutr 1992;56:933-7. [PubMed abstract]
  26. Bjerre B, von Schenck H, Sorbo B. Hyposelaemia: Patients with gastrointestinal diseases are at risk. J Intern Med 1989;225:85-8. [PubMed abstract]
  27. Gartner R, Albrich W, Angstwurm MW. The effect of a selenium supplementation on the outcome of patients with severe systemic inflammation, burn, and trauma. BioFactors 14 2001; 199-204.
  28. Berdanier, CD. Advanced Nutrition: Micronutrients. CRC Press 1998; 208-11.
  29. Derumeaux H, Valeix P, Castetbon K, Bensimon M, Boutron-Ruault MC, Arnaud J, Hercberg S. Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. Eur J Endocrinol 2003;148(3):309-15.
  30. Schrauzer GN. Commentary: Nutrition selenium supplements: Product types, quality, and safety. J Am College of Nutr 2001;20:1-4.
  31. Schrauzer GN. The nutritional significance, metabolism and toxicology of selenomethionine. Adv Food Nutr Res 2003:47:73-112.
  32. Clark LC, Combs Jr GF, Turnbull BW, Slate EH, Chalker D, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL, Park HK, Sanders BB, Smith CL, Taylor JR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. J Am Med Assoc 1996;276:1957-63.
  33. Neve J. Human selenium supplementation as assessed by changes in blood selenium concentration and glutathione peroxidase activity. J Trace Elem Med Biol 1995;9:65-73.
  34. Russo MW, Murray SC, Wurzelmann JI, Woosley JT, Sandler RS. Plasma selenium levels and the risk of colorectal adenomas. Nutr Cancer 1997;28:125-9. [PubMed abstract]
  35. Patterson BH and Levander OA. Naturally occurring selenium compounds in cancer chemoprevention trials: A workshop summary. Cancer Epidemiol Biomarkers Prev 1997;6:63-9. [PubMed abstract]
  36. Knekt P, Marniemi J, Teppo L, Heliovaara M, Aromaa A. Is low selenium status a risk factor for lung cancer? Am J Epidemiol 1998;148:975-82. [PubMed abstract]
  37. Fleet JC. Dietary selenium repletion may reduce cancer incidence in people at high risk who live in areas with low soil selenium. Nutr Rev 1997;55:277-9. [PubMed abstract]
  38. Shamberger RJ. The genotoxicity of selenium. Mutat Res 1985;154:29-48. [PubMed abstract]
  39. Young KL and Lee PN. Intervention studies on cancer. Eur J Cancer Prev 1999;8:91-103. [PubMed abstract]
  40. Burguera JL, Burguera M, Gallignani M, Alarcon OM, Burgueera JA. Blood serum selenium in the province of Merida, Venezuela, related to sex, cancer incidence and soil selenium content. J Trace Elem Electrolytes Health Dis 1990;4:73-7. [PubMed abstract]
  41. Combs GF, Jr., Clark LC, Turnbull BW. Reduction of cancer risk with an oral supplement of selenium. Biomed Environ Sci 1997;10:227-34. [PubMed abstract]
  42. Combs GF, Clark LC, Turnbull BW. An analysis of cancer prevention by selenium. BioFactors 14 2001; 153-9.
  43. Garland M, Morris JS, Stampfer MJ, Colditz GA, Spate VL, Baskett CK, Rosner B, Speier FE, Willett WC, Hunter DJ. Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst 1995;87:497- 505. [PubMed abstract]
  44. Hercberg S, Galan P, Preziosi P, Roussel AM, Arnaud J, Richard MJ, Malvy D, Paul-Dauphin A, Briancon S, Favier A. Background and rationale behind the SU.VI.MAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. Supplementation en VItamines et Mineraux AntiXydants Study. Int J Vitam Nutr Res 1998;68:3-20. [PubMed abstract]
  45. Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C. SELECT: the next prostate cancer prevention trial. Selenium and Vitamin E Cancer Prevention Trial. Journal of Urology 2001;166(4):1311-5.
  46. Gey KF. Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer. Biofactors 1998;7:113-74. [PubMed abstract]
  47. Ozer NK, Boscoboinik D, Azzi A. New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis. Biochem Mol Biol Int 1995;35:117-24. [PubMed abstract]
  48. Lapenna D, de Gioia S, Ciofani G, Mezzetti A, Ucchino S, Calafiore AM, Napolitano AM, Di Ilio C, Cuccurulo F. Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation 1998;97:1930-4. [PubMed abstract]
  49. Neve J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk 1996;3:42-7. [PubMed abstract]
  50. Kose K, Dogan P, Kardas Y, Saraymen R. Plasma selenium levels in rheumatoid arthritis. Biol Trace Elem Res 1996;53:51-6. [PubMed abstract]
  51. Heliovaara M, Knekt P, Aho K, Aaran RK, Alfthan G, Aromaa A. Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis 1994;53:51-3. [PubMed abstract]
  52. Stone J, Doube A, Dudson D, Wallace J. Inadequate calcium, folic acid, vitamin E, zinc, and selenium intake in rheumatoid arthritis patients: Results of a dietary survey. Semin Arthritis Rheum 1997;27:180-5. [PubMed abstract]
  53. Grimble RF. Nutritional antioxidants and the modulation of inflammation: Theory and practice. New Horizons 1994;2:175-85. [PubMed abstract]
  54. Aaseth J, Haugen M, Forre O. Rheumatoid arthritis and metal compounds- perspectives on the role of oxygen radical detoxification. Analyst 1998;123:3- 6. [PubMed abstract]
  55. Look MP, Rockstroh JK, Rao GS, Kreuzer KA, Spengler U, Sauerbruch T. Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res 1997;56(1):31-41.
  56. Singhal N and Austin J. A clinical review of micronutrients in HIV infection. J Int Assoc Physicians AIDS Care 2002;1:63-75.
  57. Romero-Alvira D and Roche E. The keys of oxidative stress in acquired immune deficiency syndrome apoptosis. Medical Hypotheses 1998;51(2):169-73.
  58. Patrick L. Nutrients and HIV; Part One - Beta carotene and selenium. Altern Med Rev 1999;4:403-13. [PubMed abstract]
  59. Baum MK, Shor-Posner G, Lai S, Zhang G, Lai H, Fletcher MA, Sauberlich H, Page JB. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:370-4. [PubMed abstract]
  60. Campa A, Shor-Posner G, Indacoche F, Zhang G, Lai H, Asthana D, Scott GB, Baum MK. Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retrovirol 1999;15:508-13. [PubMed abstract]
  61. Baum MK and Shor-Posner G. Micronutrient status in relationship to mortality in HIV-1 disease. Nutr Rev 1998;56:S135-9. [PubMed abstract]
  62. Koller LD and Exon JH. The two faces of selenium-deficiency and toxicity are similar in animals and man. Can J Vet Res 1986;50:297-306. [PubMed abstract]
  63. Hathcock J. Vitamins and minerals: Efficacy and safety. Am J Clin Nutr 1997;66:427-37. [PubMed abstract]
  64. Raisbeck MF, Dahl ER, Sanchez DA, Belden EL, O'Toole D. Naturally occurring selenosis in Wyoming. J Vet Diagn Invest 1993;5:84-7. [PubMed abstract]
  65. Dietary Guidelines Advisory Committee, Agricultural Research Service, United States Department of Agriculture (USDA). HG Bulletin No. 232, 2000. http://www.usda.gov/cnpp/DietGd.pdf.
  66. Center for Nutrition Policy and Promotion, United Stated Department of Agriculture. Food Guide Pyramid, 1992 (slightly revised 1996). http://www.nal.usda.gov/fnic/Fpyr/pyramid.html

Full article here


 

Selenium research center

The Selenium Nutritional Research Center (SeNRC) is involved with all nutritional and biochemical aspects of selenium research. Selenium is a dietary-essential trace element (nutritional mineral) that is critical to the body’s defense against cancer and other illnesses involving free radicals and other reactive oxygen species (ROS).

At SeNRC, we direct much of our efforts to studying the relationship of various forms of selenium compounds for the prevention of cancer. Our scientists hold patents on the use of selenium compounds and the prevention and treatment of cancer, as well as composition patents on specific selenium compounds and combinations of selenium with other nutrients and/or antioxidants. (See US 6,090,414 and EP 0 750 911 B1) Prevention is the ultimate cure. Our patents issued and allowed also cover the composition of virtually all current multivitamins now made, distributed, or sold in the U. S., whether they contain selenium or not.

SeNRC’s Research Director, Dr. Richard A. Passwater, has been involved with selenium research since 1959, when selenium was postulated to be a component of an unidentified food factor called "factor 3" in livestock feed that was thought to spare the need for vitamin E and possibly be involved in liver and muscle health of poultry and livestock.

Cancer Prevention

Dr. Passwater’s research with selenium as a cancer preventative began more than four decades ago, and over the decades, thousands of mechanistic studies, hundreds of animal studies, dozens of epidemiological (population) studies, and at least three published clinical supplementation trials have verified his findings.

On December 25, 1996, Dr. Larry Clark and his colleagues published their large, prospective, randomized, placebo-controlled, double-blind Nutritional Prevention of Cancer (NPC) clinical study in the Journal of the American Medical Association (JAMA 1996; 276:1957-1963). This landmark research effort showed that daily supplementation of diets with 200 micrograms of selenium yeast cut the cancer death rate in half. That is cancer mortality was reduced 50 percent (p=0.002). Lung cancer deaths were reduced 53% (p=0.03)

Total cancer incidence was reduced 37 percent (p=0.001) and the total carcinoma incidence was reduced 45%. In addition, the three leading sites of cancer had significantly lower incidence; lung cancer incidence was reduced 46 percent (p=0.04), prostate cancer incidence was reduced 63 percent (p=0.002) and colon cancer incidence was reduced 58 percent (p=0.03). There was a 17% reduction in all cause mortality (p=0.14), which when adjusted for sex, current smoking and age yielded a 21% reduction in deaths from all causes (p=0.07).

Visit our website


Bioactivity of selenium from Brazil nut for cancer prevention and selenoenzyme maintenance.

Ip C, Lisk DJ.

Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263.

Brazil nut (Bertholletia excelsa) is one of very few consumable products with exceptionally high levels of selenium. The mean selenium concentrations of two shipments of Brazil nut used in the present study were determined to be 16 and 30 micrograms/g. In contrast, most common foods contain much less selenium, from 0.01 to 1 micrograms/g. Previous research on selenium cancer chemoprevention invariably used a pure compound, whereas little information is available on the efficacy of selenium delivered naturally in a food form. This paper reports the results of two mammary cancer prevention experiments in the rat dimethylbenz[a]anthracene model by continuous feeding of selenium-rich Brazil nut (processed to a smooth-textured nut material for mixing in the diet). A dose-dependent inhibitory response was observed at dietary selenium concentrations of 1-3 micrograms/g. Interestingly, Brazil nut was found to be just as powerful as sodium selenite, if not more so, at similar levels of dietary selenium intake. Mammary cancer protection gland, and plasma.

The magnitude of tissue selenium accumulation was proportional to the amount of Brazil nut added to the diet. The nutritional biopotency of selenium in Brazil nut was also evaluated by the repletion of two selenoenzymes, glutathione peroxidase and type I 5'-deiodinase, in selenium-deficient rats. Supplementation with Brazil nut as the sole source of selenium produced an efficient gradient of enzyme restoration at 0.05-0.2 microgram/g of dietary selenium. A parallel comparison with sodium selenite indicated that the selenium in Brazil nut and selenite selenium were equally bioactive. Although at this point it can only be inferred that the above biologic effects are likely to be attributable to the high selenium content of Brazil nut, there is persuasive evidence to suggest that the models under investigation are responding to the selenium rather than to the other components of Brazil nut.


Selenium and cancer

Selenium is a mineral with anti-cancer properties. Many studies in the last several years have shown that selenium is a potent protective nutrient for some forms of cancer. The Arizona Cancer Center posted a selenium fact sheet listing the major functions of selenium in the body [97]. These functions are as follows:

1. Selenium is present in the active site of many enzymes, including thioredoxin reductase, which catalyze oxidation-reduction reactions. These reactions may encourage cancerous cells to under apoptosis.

2. Selenium is a component of the antioxidant enzyme glutathione peroxidase.

3. Selenium improved the immune systems' ability to respond to infections.

4. Selenium causes the formation of natural killer cells.

5. P450 enzymes in the liver may be induced by selenium, leading to detoxification of some carcinogenic molecules.

6. Selenium inhibits prostaglandins that cause inflammation.

7. Selenium enhances male fertility by increased sperm motility.

8. Selenium can decrease the rate of tumor growth.

A serendipitous randomized, double-blind, controlled trial of a 200 µg/day selenium supplement in the southeastern region of the USA (where soil selenium levels are low) found that the primary endpoints of skin cancer were not improved by the selenium supplement, but that other cancer incidence rates were decreased by selenium [98,99]. There was a significant reduction in total cancer incidence (105 vs 137 cases, P = 0.03), prostate cancer (22 vs 42 cases, P = 0.005), a marginally significant reduction in colorectal cancer incidence (9 vs 19 cases, P = 0.057), and a reduction in cancer mortality, all cancer sites (40 vs 66 deaths, P = 0.008) (selenium versus control group cases reported, respectively) [98]. The selenium supplement was most effective in ex-smokers and for those who began the study with the lowest levels of serum selenium. Several prospective studies have also examined the role of selenium in cancer prevention, particularly for prostate cancer, summarized in Table 2.

Overall, it appears that poor selenium levels, especially for men, are a cancer risk. If a person has low selenium levels and other antioxidant defenses are also low the cancer risk is increased even further. Women do not appear to be as sensitive to selenium, as breast cancer has not been found to be influenced by selenium status in several studies [100-104], although both men and women were found to be protected by higher levels of selenium from colon cancer [100] and lung cancer [105,106]. Good vegetarian sources of selenium are whole grains and legumes grown in selenium-rich soil in the western United States, brazil nuts (by far the most dense source of selenium), nutritional yeast, brewers yeast, and sunflower seeds.


Reduction of Cancer Risk by Consumption of Selenium-Enriched Plants: Enrichment of Broccoli with Selenium Increases the Anticarcinogenic Properties of Broccoli

Mar 2003, Vol. 6, No. 1: 19-26

John W. Finley, PhD
States Department of Agriculture, Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND, USA

Plant-based diets and phytochemicals present in plants are associated with decreased risk of cancer. Brassica species, and broccoli in particular, are associated with reduced risk of several important cancers. Selenium (Se) is an essential nutrient that is covalently bound in a number of different chemical forms found in plants. Broccoli accumulates Se many-fold beyond the concentration of Se in the soil, and the chemical form of Se in broccoli is similar to the chemical form in high-Se garlic, a food with unique chemoprotective properties.

Se from broccoli grown to accumulate more than 500 µg Se/g did not accumulate in rat tissues or increase glutathione peroxidase enzyme activity to the same extent as Se salts or seleno-amino acids. Se from high-Se broccoli decreased the incidence of aberrant crypts in rats with chemically induced colon cancer by more than 50%, compared with controls. Se from high-Se broccoli also decreased the incidence of mammary tumors in rats treated with 7,12-dimethylbenz(a)anthracene (DMBA) and tumor number and volume in APCmin mice.

These results suggest that development of methods to increase the natural accumulation of Se in broccoli may greatly enhance its health-promoting properties.


Brazil nuts protect from breast cancer

The mineral selenium may help protect some women from developing breast cancer, research has suggested. The element, which can be found in brazil nuts, liver and kidneys, may help the body defend itself. Scientists from the University of Illinois believe they may have worked out how selenium interacts with a natural body chemical to offer protection.

More


Selenium - daily dose

Selenium is an essential component of at least 11 selenoenzymes or selenoproteins. There are two majorfamilies of selenoenzymes?glutathione peroxidases and deiodinases. The metabolic function of the glutathione peroxidases is to convert oxidized fat (lipid hydroperoxides), which is generated as the result of normal metabolism and contributes to heart disease and stroke, to less harmful compounds. This activity is similar to the antioxidant activity of vitamin E. The deiodinase enzymes regulate the metabolism of thyroid hormones. Interestingly, the recently discovered selenoenzyme thioredoxin reductase has been suggested to play a role in vitamin C metabolism. A human disease known to be caused by selenium deficiency and found in various regions of China is Keshan disease, a cardiomyopathy (disease of the heart muscle) in children.

Extensive data from studies in China have been used to establish the required and safe levels of selenium for humans. These studies revealed significant correlations between daily selenium intake and the selenium content of blood, breast milk, and urine. Significant correlations were also observed between urinary, plasma, hair, fingernail, and toenail selenium levels.

Fingernail brittleness and hair loss were used by the Chinese scientists, as well as the Panel, as the main criteria for chronic selenium toxicity, or selenosis, which occurs at an intake of about 5 mg (5,000 mcg) of selenium daily. Adverse effects were observed at daily dietary selenium intakes between about 600 and 1,600 mcg. The maximum safe dietary selenium intake was calculated to be about 800 mcg/day, but may be as low as 600 mcg in some individuals. The Panel set the UL for selenium at 400 mcg/day, which was selected to protect sensitive individuals. The Chinese scientists suggested a level of about 40 mcg daily as the minimum requirement, which is similar to the new RDA of 55 mcg/day. This RDA established by the Panel is based on the saturation of plasma glutathione peroxidase. An intake of less than 11 mcg daily of selenium will definitely put one at risk of deficiency.

Early epidemiological studies suggested a possible inverse relationship between selenium intake in humans and the incidence of certain cancers. More than 100 relevant experiments with animals exposed to various chemical and viral carcinogens have been carried out. The majority of these studies showed anticancer effects of selenium. Three human trials on selenium and cancer have been completed, and all of them showed positive results. In one trial, the addition of selenium to table salt significantly reduced the incidence of liver cancer in a Chinese population. After 5 years of supplementation with selenium, vitamin E, and beta-carotene, the incidence of stomach and esophageal cancer in another Chinese population was significantly reduced. However, it is not clear which supplement was mainly responsible for this effect. A study in the U.S. showed that 970 men supplemented with 200 mcg of selenium daily (as selenium-enriched yeast) for 4.5 years had a 63% reduction in the incidence of prostate cancer, as well as a significantly reduced incidence of colorectal, lung, and total cancers. These supplementation studies are consistent with a recent study showing one-half to two-thirds reduction in the risk of prostate cancer among men with the highest selenium status, as assessed by toenail levels of selenium that indicate long-term selenium intake. Overall, the evidence that selenium can lower the risk of prostate and possibly other human cancers was considered very promising by the Panel, but it concluded that there is currently no proof for an anticancer effect of selenium.

It is estimated that Americans consume about 100 mcg/day of dietary selenium. In the aforementioned prostate cancer study, subjects were given 200 mcg supplements daily, which boosted their estimated daily intake to about 300 mcg. To prevent selenium deficiency symptoms, a daily intake of 55 mcg is required. For maximal protection against certain cancers, a total daily intake of 200-300 mcg is probably necessary.

Full article


Selenium is a nutritionally essential trace element that naturally occurs in the soil. It enters our bodies through our food (both plant and animal products) and, to a lesser extent, water sources. Plants absorb selenium from the soil into their leaves, stems, seeds, and fruits. Animals eat plants containing the selenium and this is stored in their tissues. Some foods that are good sources of selenium are grains grown in the Midwestern U.S. and animal meats, particularly organ meats. Certain foods like brazil nuts are especially high in selenium.

The major functions of selenium in the body that have been discovered to date are as follows:

  1. Selenium is found in the active site of many enzymes, such as thioredoxin reductase, which catalyze oxidation-reduction reactions. These reactions help to protect against cancer by encouraging cancer cells to undergo apoptosis. Apoptosis is a form of programmed cell death that occurs when genetic damage is detected in the cell, thus preventing the transfer of mutations to a future generation of cells.
  2. An enzyme, Glutathione Peroxidase (or GSH-PX) requires selenium for its formation. This enzyme helps to prevent a process called oxidation, which may cause injury in cells.
  3. Selenium appears to improve the functioning of the immune system and its response to infections.
  4. Selenium appears to cause the formation of natural killer cells, which destroy foreign bacteria that enters the body.
  5. P450 enzymes may be induced by selenium. These enzymes help detoxify some cancer-causing substances.
  6. Selenium inhibits prostaglandins, which cause inflammatory reactions in the body.
  7. Male fertility may be enhanced by selenium due to increased sperm motility.
  8. At high doses, selenium may decrease the rates of tumor cell growth.

Selenium can be toxic at very high doses. This was first observed in animals that eat plants with toxic levels of selenium. Toxicity in humans has rarely been seen. However, toxicity has been reported in parts of the world where dietary selenium levels are extremely high. The reported symptoms of human toxicity from selenium have included increased nail and hair brittleness or crumbling, skin rashes, "pins and needles" sensations, irritability, nausea, vomiting, or garlic breath. These side effects were observed in approximately 10% of Chinese subjects consuming a diet with over 1,000 micrograms of selenium daily.

Source: Arizona University


Vrijwilligers gezocht

U zult begrijpen dat wij onmogelijk alles alleen kunnen doen dus mocht je willen helpen bij een bepaald thema, vertaalwerk, links bezoeken etc dan is alle hulp welkom.

Mvg

Ron Fonteine
Email adres: ugamedia@wirehub.nl


Aanmelden van nuttige links, adviezen, persoonlijke
ervaringen mbt kanker etc

Naam
Email

Omschrijving / feedback


 

Zoeken
Thema's
Algemeen
Alvleesklierkanker
Anuskanker
Baarmoederkanker
Blaaskanker
Bloedkanker
Borstkanker
Botkanker
Darmkanker
Galkanker
Hersentumor
Huidkanker
Keelkanker
Leverkanker
Lymfeklierkanker
Longkanker
Maagkanker
Oogkanker
Nierkanker
Prostaatkanker
Schildklierkanker
Slokdarmkanker
Zaadbalkanker

Internationaal

Algemeen
Borstkanker
Darmkanker
Prostaatkanker

Alternatief

Budwig
Dr Rath
Moerman
Houtsmuller
Vitamine C
Links
Gezonde voeding
Vitamine C
Fitness gids
Supervoeding




View My Stats